Beranda › Penyakit Crohn › Texas › Houston
Uji klinis Penyakit Crohn di Houston, TX
17 studi untuk Penyakit Crohn mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Menerima pesertaFase 3
- Baylor College of Medicine Medical Center ( Site 5020), Houston
- Michael E. DeBakey VA Medical Center ( Site 5086), Houston
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Menerima pesertaFase 2
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · 7 mi jauhnya
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Menerima pesertaFase 4
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Menerima pesertaFase 2
- Houston Methodist Hospital /ID# 265533, Houston
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2/3
- Victorium Clinical Research, Houston
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2
- Novel Research, LLC, Bellaire · 7 mi jauhnya
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- UT MD Anderson Cancer Center, Houston
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2
- The University of Texas Health Science Center at Houston, Houston
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Menerima pesertaFase 4
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Menerima pesertaStudi observasional
- BAMC, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Menerima peserta
- Baylor College of Medicine, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Menerima pesertaStudi observasional
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Menerima pesertaFase 3
- Texas Children's Hospital - Baylor - PIN, Houston
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Menerima pesertaFase 3
- Texas Children's Hospital, Houston
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2
- Houston Methodist Hospital, Houston
- Novel Research, LLC, Bellaire · 7 mi jauhnya
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Menerima pesertaFase 2
- Mirador Therapeutics Selected Site, Houston
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Menerima pesertaFase 4
- Houston Methodist Hospital, Houston
Uji klinis Penyakit Crohn di kota lain
- New York City, NY35 studi
- Cleveland, OH19 studi
- St. Louis, MO19 studi
- Boston, MA19 studi
- Miami, FL19 studi
- Orlando, FL17 studi
- Atlanta, GA17 studi
- Tyler, TX16 studi
- San Diego, CA15 studi
- San Antonio, TX15 studi
- Los Angeles, CA15 studi
- Philadelphia, PA13 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.